MOTIV

AssetAlso MOTIV®

Bioresorbable scaffold for below-the-knee revascularization

Stage
Human trials
Modality
Device
Target
Not known
3
Indications
0
Trials
1
Developer

Indications

3
  • Below-the-knee revascularization

    Human trials, prnewswire.com, 6 Oct 2026

  • Chronic limb-threatening ischemia

    Human trials, prnewswire.com, 6 Oct 2026

  • Critical limb threat ischemia

    Human trials, prnewswire.com, 6 Oct 2026

In the full profile

  • Owner and partners1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets